FDA Inspection
Baxter CorporationBaxter Corporation – FDA Inspection, Jan 31, 2025
Record Details
This FDA Inspection record concerns Baxter Corporation, with an inspection on January 31, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 37423882-4793-4df1-befc-f6f2a3fd88d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1259651
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Corporation
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 8, 2010 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Baxter Corporation
- FDA Inspection 1102280 - 2019-09-17
- FDA Inspection 943637 - 2015-07-30
- FDA Inspection 659975 - 2010-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.